Metraipolis › archive › dc_d168a4c916bc
Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small… — Europe PMC PMID:41892201
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41892201
- DOI
- 10.3390/curroncol33030173
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T06:46:52.329Z
- SHA-256 of the archived text
b32052f98b031fc306e9978aac17dbe43141687c4392e47462774c27e44e18bb- Stable URL of this page
https://metraipolis.com/documento/dc_d168a4c916bc
How to cite
Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small… — Europe PMC PMID:41892201 — Europe PMC (en), https://europepmc.org/article/MED/41892201 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d168a4c916bc (Metraipolis archive dc_d168a4c916bc, sha256 b32052f98b031fc306e9978aac17dbe43141687c4392e47462774c27e44e18bb)
BibTeX
@misc{dcd168a4c916bc,
title = {Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small… — Europe PMC PMID:41892201},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41892201},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d168a4c916bc; sha256 b32052f98b031fc306e9978aac17dbe43141687c4392e47462774c27e44e18bb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892201. Agents can read the archived copy with the MCP tool read_document.